CymitQuimica logo

Atuveciclib (BAY-1143572)

CAS:

Ref. 3D-PGC94388

5mg
570.00€
10mg
864.00€
25mg
1,527.00€
50mg
2,379.00€
Atuveciclib (BAY-1143572)
Biosynth

Product Information

Name:Atuveciclib (BAY-1143572)
Brand:Biosynth
Description:Atuveciclib is a selective inhibitor of CDK4 and CDK6 that has been shown to inhibit the growth of cancer cells in vitro. It was also shown to be effective in vivo, reducing the size of tumors in mice with bowel disease. Atuveciclib has been shown to inhibit lymphoproliferative disorders by targeting the mcl-1 protein, which is essential for cell survival. This drug inhibits the production of inflammatory cytokines such as IL-2, IL-3 and erythropoietin, which are responsible for the development of lymphoproliferative disorders. Atuveciclib has a short detection time and pharmacokinetic properties that enable it to be administered intravenously or orally. It also shows selectivity for kinases over other proteins, making it an attractive potential treatment for inflammatory bowel disease or cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:387.43 g/mol
Formula:C18H18FN5O2S
Purity:Min. 95%

Technical inquiry about: Atuveciclib (BAY-1143572)

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.